BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 21768920)

  • 1. Case-control study of the effectiveness of vaccination with pentavalent rotavirus vaccine in Nicaragua.
    Mast TC; Khawaja S; Espinoza F; Paniagua M; Del Carmen LP; Cardellino A; Sánchez E
    Pediatr Infect Dis J; 2011 Nov; 30(11):e209-15. PubMed ID: 21768920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States.
    Boom JA; Tate JE; Sahni LC; Rench MA; Hull JJ; Gentsch JR; Patel MM; Baker CJ; Parashar UD
    Pediatrics; 2010 Feb; 125(2):e199-207. PubMed ID: 20083525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of vaccination with the pentavalent rotavirus vaccine in Nicaragua as determined using the screening method.
    Cardellino A; Khawaja S; Sánchez Cruz E; Mast TC
    Hum Vaccin Immunother; 2013 Jul; 9(7):1449-53. PubMed ID: 23571175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in gastroenteritis with the use of pentavalent rotavirus vaccine in a primary practice.
    Bégué RE; Perrin K
    Pediatrics; 2010 Jul; 126(1):e40-5. PubMed ID: 20587671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States.
    Wang FT; Mast TC; Glass RJ; Loughlin J; Seeger JD
    Pediatrics; 2010 Feb; 125(2):e208-13. PubMed ID: 20100757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of protection of pentavalent rotavirus vaccination in Nicaragua.
    Patel M; Pedreira C; De Oliveira LH; Umaña J; Tate J; Lopman B; Sanchez E; Reyes M; Mercado J; Gonzalez A; Perez MC; Balmaceda A; Andrus J; Parashar U
    Pediatrics; 2012 Aug; 130(2):e365-72. PubMed ID: 22753550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rotavirus disease burden, Nicaragua 2001-2005: defining the potential impact of a rotavirus vaccination program.
    Amador JJ; Vasquez J; Orozco M; Pedreira C; Malespin O; De Oliveira LH; Tate J; Parashar U; Patel M
    Int J Infect Dis; 2010 Jul; 14(7):e592-5. PubMed ID: 20022778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The uptake of rotavirus vaccine and its effectiveness in preventing acute gastroenteritis in the community.
    Muhsen K; Chodick G; Goren S; Shalev V; Cohen D
    Vaccine; 2010 Dec; 29(1):91-4. PubMed ID: 20969927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua.
    Patel M; Pedreira C; De Oliveira LH; Tate J; Orozco M; Mercado J; Gonzalez A; Malespin O; Amador JJ; Umaña J; Balmaseda A; Perez MC; Gentsch J; Kerin T; Hull J; Mijatovic S; Andrus J; Parashar U
    JAMA; 2009 Jun; 301(21):2243-51. PubMed ID: 19491186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of an incomplete RotaTeq (RV5) vaccination regimen in preventing rotavirus gastroenteritis in the United States.
    Wang FT; Mast TC; Glass RJ; Loughlin J; Seeger JD
    Pediatr Infect Dis J; 2013 Mar; 32(3):278-83. PubMed ID: 23014356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.
    Buttery JP; Lambert SB; Grimwood K; Nissen MD; Field EJ; Macartney KK; Akikusa JD; Kelly JJ; Kirkwood CD
    Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S25-9. PubMed ID: 21183837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Lanzhou lamb rotavirus vaccine against rotavirus gastroenteritis requiring hospitalization: a matched case-control study.
    Fu C; Wang M; Liang J; He T; Wang D; Xu J
    Vaccine; 2007 Dec; 25(52):8756-61. PubMed ID: 18023510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-World Effectiveness of Pentavalent Rotavirus Vaccine Among Bedouin and Jewish Children in Southern Israel.
    Leshem E; Givon-Lavi N; Tate JE; Greenberg D; Parashar UD; Dagan R
    Clin Infect Dis; 2016 May; 62 Suppl 2():S155-60. PubMed ID: 27059350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake of rotavirus vaccine and national trends of acute gastroenteritis among children in Nicaragua.
    Orozco M; Vasquez J; Pedreira C; De Oliveira LH; Amador JJ; Malespin O; Andrus J; Tate J; Parashar U; Patel M
    J Infect Dis; 2009 Nov; 200 Suppl 1():S125-30. PubMed ID: 19821709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre, Spain.
    Castilla J; Beristain X; Martínez-Artola V; Navascués A; García Cenoz M; Alvarez N; Polo I; Mazón A; Gil-Setas A; Barricarte A
    Vaccine; 2012 Jan; 30(3):539-43. PubMed ID: 22122860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in Kenya.
    Feikin DR; Laserson KF; Ojwando J; Nyambane G; Ssempijja V; Audi A; Nyakundi D; Oyieko J; Dallas MJ; Ciarlet M; Neuzil KM; Breiman RF
    Vaccine; 2012 Apr; 30 Suppl 1():A52-60. PubMed ID: 22520137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States.
    Payne DC; Staat MA; Edwards KM; Szilagyi PG; Gentsch JR; Stockman LJ; Curns AT; Griffin M; Weinberg GA; Hall CB; Fairbrother G; Alexander J; Parashar UD
    Pediatrics; 2008 Dec; 122(6):1235-43. PubMed ID: 19047240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa.
    Tapia MD; Armah G; Breiman RF; Dallas MJ; Lewis KD; Sow SO; Rivers SB; Levine MM; Laserson KF; Feikin DR; Victor JC; Ciarlet M; Neuzil KM; Steele AD
    Vaccine; 2012 Apr; 30 Suppl 1():A79-85. PubMed ID: 22520141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine.
    Breiman RF; Zaman K; Armah G; Sow SO; Anh DD; Victor JC; Hille D; Ciarlet M; Neuzil KM
    Vaccine; 2012 Apr; 30 Suppl 1():A24-9. PubMed ID: 22520132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of a pentavalent human-bovine reassortant rotavirus vaccine for children ≤5 years of age in Taiwan.
    Itzler RF; Chen PY; Lac C; El Khoury AC; Cook JR
    J Med Econ; 2011; 14(6):748-58. PubMed ID: 21919673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.